Coming to Grips with Obesity

Science is approaching a better understanding of the increasingly prevalent disease; the consequences of succeeding in this quest are great.

Written byRudy Leibel
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© ISTOCK.COM/WRAGGWithin the past 40 years, obesity has become more common in virtually all age groups in the U.S., and more recently, throughout much of the world. It has become clear, through the calculation of concordance rates in twin-pair and adoption studies, that 25–50 percent of the risk of obesity is heritable, the extent varying within specific environments. And cogent arguments can be made regarding the evolutionary enrichment of our genomes with alleles favoring the conservation of calories.

Body fat, which provides a calorically dense, disposable energy source, is critical to the functional integrity of the reproductive system and to survival in circumstances of caloric deprivation. Studies of weight perturbation in animals and humans indicate that the loss of body fat is defended against more vigorously than its gain. This makes sense if one assumes that we are the products of evolutionary processes designed to optimize survival in circumstances of limited food and to key reproduction to environmental circumstance. And this model is certainly consistent with the observation that humans more easily gain weight than lose it and sustain that loss.

But human genetic makeup has not changed sufficiently over the past several decades, so to account for recent major phenotypic shifts something ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies